Deciphering the role of Th17 cells in human disease.

PubWeight™: 1.76‹?› | Rank: Top 3%

🔗 View Article (PMC 3224806)

Published in Trends Immunol on September 28, 2011

Authors

Cailin Moira Wilke1, Keith Bishop, David Fox, Weiping Zou

Author Affiliations

1: Department of Surgery, University of Michigan Medical School, Ann Arbor, MI 48109, USA.

Articles citing this

The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science (2016) 2.58

Essentials of Th17 cell commitment and plasticity. Blood (2013) 1.95

Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells. Arthritis Rheum (2013) 1.71

Adaptive immunity in atherogenesis: new insights and therapeutic approaches. J Clin Invest (2013) 1.43

IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases. Nat Med (2015) 1.32

Targeting T cell metabolism for therapy. Trends Immunol (2015) 1.27

TH17 Cells in Autoimmunity and Immunodeficiency: Protective or Pathogenic? Front Immunol (2012) 1.17

High CTLA-4 expression on Th17 cells results in increased sensitivity to CTLA-4 coinhibition and resistance to belatacept. Am J Transplant (2014) 1.05

Th17 cells and Tregs: unlikely allies. J Leukoc Biol (2014) 1.03

T cell–derived inducible nitric oxide synthase switches off Th17 cell differentiation. J Exp Med (2013) 1.03

Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk. Cancer Epidemiol Biomarkers Prev (2012) 1.01

Induction and stability of human Th17 cells require endogenous NOS2 and cGMP-dependent NO signaling. J Exp Med (2013) 0.99

Expanding roles for CD4 T cells and their subpopulations in tumor immunity and therapy. Front Oncol (2013) 0.99

Administration of interleukin-17 soluble receptor C suppresses TH17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy. Hypertension (2013) 0.98

Host response signature to Staphylococcus aureus alpha-hemolysin implicates pulmonary Th17 response. Infect Immun (2012) 0.98

Molecular pathogenesis of neuromyelitis optica. Int J Mol Sci (2012) 0.92

Immune disorders in Hashimoto's thyroiditis: what do we know so far? J Immunol Res (2015) 0.91

Strain-dependent production of interleukin-17/interferon-γ and matrix remodeling-associated genes in experimental Candida albicans keratitis. Mol Vis (2012) 0.90

The linkage of innate and adaptive immune response during granulomatous development. Front Immunol (2013) 0.89

Human ovarian tumor ascites fluids rapidly and reversibly inhibit T cell receptor-induced NF-κB and NFAT signaling in tumor-associated T cells. Cancer Immun (2013) 0.89

Immune response and the tumor microenvironment: how they communicate to regulate gastric cancer. Gut Liver (2014) 0.88

T lymphocyte subset imbalances in patients contribute to ankylosing spondylitis. Exp Ther Med (2014) 0.88

Deletion of Braun lipoprotein and plasminogen-activating protease-encoding genes attenuates Yersinia pestis in mouse models of bubonic and pneumonic plague. Infect Immun (2014) 0.86

The dynamic lives of T cells: new approaches and themes. Trends Immunol (2012) 0.85

The multifaceted role of Th17 lymphocytes and their associated cytokines in cancer. Clin Dev Immunol (2013) 0.85

IL-17A, IL-17F and IL-23R Gene Polymorphisms in Polish Patients with Rheumatoid Arthritis. Arch Immunol Ther Exp (Warsz) (2014) 0.84

In vitro generated Th17 cells support the expansion and phenotypic stability of CD4(+)Foxp3(+) regulatory T cells in vivo. Cytokine (2013) 0.84

T cells in gastric cancer: friends or foes. Clin Dev Immunol (2012) 0.83

Higher levels of interleukin IL-17 and antigen-specific IL-17 responses in pulmonary sarcoidosis patients with Löfgren's syndrome. Clin Exp Immunol (2014) 0.83

Imbalanced frequencies of Th17 and Treg cells in acute coronary syndromes are mediated by IL-6-STAT3 signaling. PLoS One (2013) 0.82

Role of miRNAs in CD4 T cell plasticity during inflammation and tolerance. Front Genet (2013) 0.82

The expression levels of transcription factors T-bet, GATA-3, RORγt and FOXP3 in peripheral blood lymphocyte (PBL) of patients with liver cancer and their significance. Int J Med Sci (2015) 0.81

New perspective on dextran sodium sulfate colitis: antigen-specific T cell development during intestinal inflammation. PLoS One (2013) 0.81

Preferential expression of functional IL-17R in glioma stem cells: potential role in self-renewal. Oncotarget (2016) 0.81

Transforming growth factor-β protein inversely regulates in vivo differentiation of interleukin-17 (IL-17)-producing CD4+ and CD8+ T cells. J Biol Chem (2011) 0.80

Photo(chemo)therapy reduces circulating Th17 cells and restores circulating regulatory T cells in psoriasis. PLoS One (2013) 0.80

CD3-T cell receptor co-stimulation through SLAMF3 and SLAMF6 receptors enhances RORγt recruitment to the IL17A promoter in human T lymphocytes. J Biol Chem (2012) 0.80

Amelioration of experimental autoimmune uveitis by leflunomide in Lewis rats. PLoS One (2013) 0.80

Effects of Systemically Administered Hydrocortisone on the Human Immunome. Sci Rep (2016) 0.79

T-helper 17-related cytokines and IgE antibodies during hepatitis A virus infection in children. Mem Inst Oswaldo Cruz (2015) 0.79

Biotin deficiency enhances the inflammatory response of human dendritic cells. Am J Physiol Cell Physiol (2016) 0.79

Myelin-specific T helper 17 cells promote adult hippocampal neurogenesis through indirect mechanisms. F1000Res (2014) 0.79

Cellular and molecular immunology of lung cancer: therapeutic implications. Expert Rev Clin Immunol (2014) 0.79

Role of IL-17 in Glioma Progression. J Spine Neurosurg (2013) 0.77

Endothelin-1 is not a Mechanism of IL-17 Induced Hypertension during Pregnancy. Med J Obstet Gynecol (2013) 0.77

Vitamin D deficiency contributes to the reduction and impaired function of naïve CD45RA⁺ regulatory T cell in chronic heart failure. J Immunol Res (2015) 0.77

Differential inflammatory response to Helicobacter pylori infection: etiology and clinical outcomes. J Inflamm Res (2015) 0.76

Biomarkers to Diagnose Early Arthritis in Patients With Psoriasis. Psoriasis Forum (2012) 0.76

Skewed T-helper (Th)1/2- and Th17/T regulatory‑cell balances in patients with renal cell carcinoma. Mol Med Rep (2014) 0.76

Bronchial airway gene expression in smokers with lung or head and neck cancer. Cancer Med (2014) 0.76

Control of the adaptive immune response by tumor vasculature. Front Oncol (2014) 0.76

The correlation between T helper type 17 cells and clinical characters in Chinese paediatric patients with chronic hepatitis B. Clin Exp Immunol (2013) 0.76

Monocyte-derived dendritic cells from Crohn's disease patients exhibit decreased ability to activate T helper type 17 responses in memory cells. Clin Exp Immunol (2014) 0.75

Alarmins and Their Receptors as Modulators and Indicators of Alloimmune Responses. Am J Transplant (2016) 0.75

Presence of IL-17 in synovial fluid identifies a potential inflammatory osteoarthritic phenotype. PLoS One (2017) 0.75

Role of cytolytic impairment of natural killer and natural killer T-cell populations in rheumatoid arthritis. Clin Rheumatol (2014) 0.75

Intestinal inflammation and the diet: Is food friend or foe? World J Gastrointest Surg (2016) 0.75

FOXP3(+) associated with the pro-inflammatory regulatory T and T helper 17 effector cells in asthma patients. Exp Ther Med (2016) 0.75

Interleukin-17 augments tumor necrosis factor α-mediated increase of hypoxia-inducible factor-1α and inhibits vasodilator-stimulated phosphoprotein expression to reduce the adhesion of breast cancer cells. Oncol Lett (2017) 0.75

5-Fluorouracil targets thymidylate synthase in the selective suppression of TH17 cell differentiation. Oncotarget (2016) 0.75

Comparative analysis of human and mouse transcriptomes of Th17 cell priming. Oncotarget (2016) 0.75

Reduced Uterine Perfusion Pressure T-helper 17 cells cause Pathophysiology Associated with Preeclampsia during Pregnancy. Am J Physiol Regul Integr Comp Physiol (2016) 0.75

Role of T helper 17 cytokines in the tumour immune inflammation response of patients with laryngeal squamous cell carcinoma. Oncol Lett (2017) 0.75

Articles cited by this

(truncated to the top 100)

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science (2006) 27.49

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med (2004) 22.96

IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest (2006) 11.89

Phenotypic and functional features of human Th17 cells. J Exp Med (2007) 11.33

TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol (2007) 11.14

Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer (2005) 10.06

Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol (2006) 9.42

TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol (2008) 8.95

Late developmental plasticity in the T helper 17 lineage. Immunity (2009) 8.81

Inhibitory B7-family molecules in the tumour microenvironment. Nat Rev Immunol (2008) 8.17

Anti-interleukin-12 antibody for active Crohn's disease. N Engl J Med (2004) 7.93

Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med (2006) 7.76

Induction and effector functions of T(H)17 cells. Nature (2008) 7.75

A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med (2009) 7.45

Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med (2003) 7.35

Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum (1999) 6.39

Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med (2007) 6.19

Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol (1999) 6.15

IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J Exp Med (2006) 5.76

Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med (2006) 5.63

A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med (2007) 5.39

Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med (2010) 4.95

Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler (1999) 4.91

Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood (2009) 4.80

T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat Med (2010) 4.78

Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest (2009) 4.74

Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol (1993) 4.68

High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol (2000) 4.58

Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J Exp Med (2008) 4.30

Th17 cells in human disease. Immunol Rev (2008) 4.27

Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood (2009) 4.13

Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med (2001) 3.81

Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol (2007) 3.81

B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J Exp Med (2006) 3.75

Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet (2008) 3.71

Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med (2007) 3.68

Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am J Respir Cell Mol Biol (2003) 3.60

MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol (2009) 3.48

Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur J Immunol (2009) 3.42

T(H)17 cells in tumour immunity and immunotherapy. Nat Rev Immunol (2010) 3.39

IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest (2007) 3.31

Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol (2008) 3.22

Effector T cell plasticity: flexibility in the face of changing circumstances. Nat Immunol (2010) 3.12

Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing. Clin Cancer Res (2008) 3.09

LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study. Arthritis Rheum (2010) 2.99

Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J Exp Med (2009) 2.82

Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective. Nat Rev Immunol (2009) 2.65

T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. J Allergy Clin Immunol (2009) 2.54

Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease. Gut (2009) 2.48

Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci (1992) 2.47

Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc Natl Acad Sci U S A (2010) 2.43

Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir Med (2003) 2.26

Role of Th17 cells in human autoimmune arthritis. Arthritis Rheum (2010) 2.25

Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis. Arthritis Rheum (2011) 2.24

Cutting edge: opposite effects of IL-1 and IL-2 on the regulation of IL-17+ T cell pool IL-1 subverts IL-2-mediated suppression. J Immunol (2007) 2.21

Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest (1995) 2.20

Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J Invest Dermatol (2008) 2.19

Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort). Arthritis Rheum (2006) 2.17

Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain (2005) 2.07

Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Res (2005) 2.06

CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. Eur J Immunol (2010) 2.03

Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4. J Allergy Clin Immunol (2010) 2.02

Upregulation of interleukin-12 and -17 in active inflammatory bowel disease. Scand J Gastroenterol (2003) 1.91

Th17 cytokines and mucosal immunity. Immunol Rev (2008) 1.80

Interleukin-17A promotes IgE production in human B cells. J Invest Dermatol (2010) 1.79

IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer. J Immunol (2011) 1.76

Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology. J Exp Med (2010) 1.70

Induction of glucocorticoid receptor-beta expression in epithelial cells of asthmatic airways by T-helper type 17 cytokines. Clin Exp Allergy (2010) 1.70

Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production. Arthritis Rheum (2011) 1.68

Th17 cells: new players in asthma pathogenesis. Allergy (2011) 1.64

Expression of αvβ8 integrin on dendritic cells regulates Th17 cell development and experimental autoimmune encephalomyelitis in mice. J Clin Invest (2010) 1.63

Cells of the synovium in rheumatoid arthritis. T lymphocytes. Arthritis Res Ther (2007) 1.63

Th17 immunity in patients with allergic asthma. Int Arch Allergy Immunol (2009) 1.58

The role of interleukin-17 during acute rejection after lung transplantation. Eur Respir J (2006) 1.56

An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis. J Immunol (2006) 1.54

Expression of IL-17 homologs and their receptors in the synovial cells of rheumatoid arthritis patients. Mol Cells (2005) 1.41

Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes. Ann Rheum Dis (2011) 1.40

T helper17 cells are sufficient but not necessary to induce acute graft-versus-host disease. Biol Blood Marrow Transplant (2009) 1.37

Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways. Mol Cancer (2010) 1.28

Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection. J Immunol (2010) 1.28

Generation and differentiation of IL-17-producing CD4+ T cells in malignant pleural effusion. J Immunol (2010) 1.26

Identification of a cytokine network sustaining neutrophil and Th17 activation in untreated early rheumatoid arthritis. Arthritis Res Ther (2010) 1.25

Pretreatment frequency of circulating IL-17+ CD4+ T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients. Int J Cancer (2009) 1.24

αv Integrin expression by DCs is required for Th17 cell differentiation and development of experimental autoimmune encephalomyelitis in mice. J Clin Invest (2010) 1.23

Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation. Transplantation (2009) 1.14

Th17 cells, not IL-17+ γδ T cells, drive arthritic bone destruction in mice and humans. J Immunol (2011) 1.14

Glycogen synthase kinase-3 is an early determinant in the differentiation of pathogenic Th17 cells. J Immunol (2010) 1.13

Changes in the serum levels of interleukin-17/interleukin-23 during acute rejection in liver transplantation. Liver Transpl (2009) 1.13

Role of T cell TGFbeta signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection. J Immunol (2009) 1.12

Intratumoral expression of IL-17 and its prognostic role in gastric adenocarcinoma patients. Int J Biol Sci (2011) 1.10

Phenotype and effector function of CC chemokine receptor 9-expressing lymphocytes in small intestinal Crohn's disease. J Immunol (2007) 1.09

The transient nature of the Th17 phenotype. Eur J Immunol (2010) 1.04

Induction of a regulatory B cell population in experimental allergic encephalomyelitis by alteration of the gut commensal microflora. Gut Microbes (2010) 1.00

Interleukin-17 is a potent immuno-modulator and regulator of normal human intestinal epithelial cell growth. Biochem Biophys Res Commun (2005) 0.98

Molecular interactions between T cells and fibroblast-like synoviocytes: role of membrane tumor necrosis factor-alpha on cytokine-activated T cells. Am J Pathol (2007) 0.98

B cells as a therapeutic target for IFN-β in relapsing-remitting multiple sclerosis. J Immunol (2011) 0.97

Sensitivity and resistance to regulation by IL-4 during Th17 maturation. J Immunol (2011) 0.97

A phase 1/2A trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn's disease. Inflamm Bowel Dis (2006) 0.97

Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. Clin Immunol (2010) 0.96

PPARδ deficient mice develop elevated Th1/Th17 responses and prolonged experimental autoimmune encephalomyelitis. Brain Res (2010) 0.95

Articles by these authors

(truncated to the top 100)

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med (2004) 22.96

Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med (2003) 7.35

Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood (2009) 4.80

Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood (2009) 4.13

Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol (2007) 3.81

B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J Exp Med (2006) 3.75

Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex. Proc Natl Acad Sci U S A (2003) 3.37

Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol (2008) 3.22

Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis. Genes Dev (2011) 3.05

Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells. J Immunol (2006) 2.50

CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res (2005) 2.38

Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am J Physiol Cell Physiol (2006) 2.36

Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res (2004) 2.28

Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology (2009) 2.22

Cutting edge: opposite effects of IL-1 and IL-2 on the regulation of IL-17+ T cell pool IL-1 subverts IL-2-mediated suppression. J Immunol (2007) 2.21

The contribution of transcription factor IRF1 to the interferon-gamma-interleukin 12 signaling axis and TH1 versus TH-17 differentiation of CD4+ T cells. Nat Immunol (2007) 2.15

Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Res (2005) 2.06

Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells. Int J Cancer (2011) 2.05

Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma. Cancer Res (2007) 2.01

Human TH17 cells are long-lived effector memory cells. Sci Transl Med (2011) 1.99

Regulatory T cells in ovarian cancer: biology and therapeutic potential. Am J Reprod Immunol (2005) 1.96

Regulatory T-cell compartmentalization and trafficking. Blood (2006) 1.86

T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment. Curr Opin Immunol (2013) 1.79

Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2. Immunity (2013) 1.77

IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer. J Immunol (2011) 1.76

A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity. Proc Natl Acad Sci U S A (2008) 1.75

Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma. Cancer Res (2007) 1.66

Th17 cells in cancer: help or hindrance? Carcinogenesis (2011) 1.63

FOXP3 defines regulatory T cells in human tumor and autoimmune disease. Cancer Res (2009) 1.63

Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma. Hepatology (2012) 1.47

Top3β is an RNA topoisomerase that works with fragile X syndrome protein to promote synapse formation. Nat Neurosci (2013) 1.46

Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions. Cancer Res (2009) 1.39

Tumor-induced immune suppression of in vivo effector T-cell priming is mediated by the B7-H1/PD-1 axis and transforming growth factor beta. Cancer Res (2008) 1.38

Rif1 provides a new DNA-binding interface for the Bloom syndrome complex to maintain normal replication. EMBO J (2010) 1.36

NF-κB inhibits osteogenic differentiation of mesenchymal stem cells by promoting β-catenin degradation. Proc Natl Acad Sci U S A (2013) 1.35

Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer. Cancer Res (2004) 1.35

Dual biological effects of the cytokines interleukin-10 and interferon-γ. Cancer Immunol Immunother (2011) 1.34

Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma. Am J Clin Nutr (2013) 1.29

Selective survival of peripheral blood lymphocytes in children with HIV-1 following delivery of an anti-HIV gene to bone marrow CD34(+) cells. Mol Ther (2005) 1.28

Conservation, surface exposure, and in vivo expression of the Frp family of iron-regulated cell wall proteins in Staphylococcus aureus. Infect Immun (2002) 1.25

Prognostic significance of regulatory T cells in tumor. Int J Cancer (2010) 1.24

Altering regulatory T cell function in cancer immunotherapy: a novel means to boost the efficacy of cancer vaccines. Front Biosci (Landmark Ed) (2009) 1.23

CD molecules 2006--human cell differentiation molecules. J Immunol Methods (2006) 1.23

Interleukin-10 ablation promotes tumor development, growth, and metastasis. Cancer Res (2011) 1.22

Combining functional and structural genomics to sample the essential Burkholderia structome. PLoS One (2013) 1.21

Cutting edge: IFN-gamma enables APC to promote memory Th17 and abate Th1 cell development. J Immunol (2008) 1.20

A ubiquitin-binding protein, FAAP20, links RNF8-mediated ubiquitination to the Fanconi anemia DNA repair network. Mol Cell (2012) 1.19

RecQL5 promotes genome stabilization through two parallel mechanisms--interacting with RNA polymerase II and acting as a helicase. Mol Cell Biol (2010) 1.17

Bone marrow and the control of immunity. Cell Mol Immunol (2011) 1.15

A crucial role for host APCs in the induction of donor CD4+CD25+ regulatory T cell-mediated suppression of experimental graft-versus-host disease. J Immunol (2010) 1.14

Retigabine for the adjunctive treatment of adults with partial-onset seizures in epilepsy with and without secondary generalization : a NICE single technology appraisal. Pharmacoeconomics (2013) 1.13

Role of T cell TGFbeta signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection. J Immunol (2009) 1.12

Targeting regulatory T cells. Target Oncol (2012) 1.10

Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer. Oncoimmunology (2012) 1.08

Development of a murine model of chronic rhinosinusitis. Otolaryngol Head Neck Surg (2006) 1.02

Induction of antigen-specific regulatory T lymphocytes by human dendritic cells expressing the glucocorticoid-induced leucine zipper. Blood (2007) 1.01

Synbindin in extracellular signal-regulated protein kinase spatial regulation and gastric cancer aggressiveness. J Natl Cancer Inst (2013) 1.01

A variant of the breast cancer type 2 susceptibility protein (BRC) repeat is essential for the RECQL5 helicase to interact with RAD51 recombinase for genome stabilization. J Biol Chem (2012) 1.01

A nonintrinsic regional basis for increased infrarenal aortic MMP-9 expression and activity. J Vasc Surg (2003) 1.00

Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation. Liver Int (2005) 0.99

Th17 cells have stem cell-like features and promote long-term immunity. Oncoimmunology (2012) 0.98

Regulatory T cells: a new frontier in cancer immunotherapy. Adv Exp Med Biol (2008) 0.97

Toxoplasma gondii-infected human myeloid dendritic cells induce T-lymphocyte dysfunction and contact-dependent apoptosis. Infect Immun (2002) 0.97

New comparative genomics approach reveals a conserved health span signature across species. Aging (Albany NY) (2011) 0.96

Detection of prions in the faeces of sheep naturally infected with classical scrapie. Vet Res (2011) 0.96

Antigen-presenting cell (APC) subsets in ovarian cancer. Int Rev Immunol (2011) 0.93

TLR2 mediates Helicobacter pylori-induced tolerogenic immune response in mice. PLoS One (2013) 0.93

Regulatory T cells in human ovarian cancer. J Oncol (2012) 0.90

Retracted Role of STAT3 and vitamin D receptor in EZH2-mediated invasion of human colorectal cancer. J Pathol (2013) 0.90

Membrane-type I matrix metalloproteinase-dependent regulation of rheumatoid arthritis synoviocyte function. J Immunol (2010) 0.89

Promoter binding by the Adr1 transcriptional activator may be regulated by phosphorylation in the DNA-binding region. PLoS One (2008) 0.87

Tunable-focus liquid lens controlled using a servo motor. Opt Express (2006) 0.87

The interaction of ruminant PrP(Sc) with soils is influenced by prion source and soil type. Environ Sci Technol (2010) 0.87

Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease. J Transl Med (2011) 0.86

A structural biology approach enables the development of antimicrobials targeting bacterial immunophilins. Antimicrob Agents Chemother (2013) 0.86

Differentiating ovine BSE from CH1641 scrapie by serial protein misfolding cyclic amplification. Mol Biotechnol (2012) 0.85

HosA, a member of the SlyA family, regulates motility in enteropathogenic Escherichia coli. Infect Immun (2005) 0.84

Blocking HDACs boosts regulatory T cells. Nat Med (2007) 0.83

The chemokine SDF-1/CXCL12 contributes to T lymphocyte recruitment in human pre-ovulatory follicles and coordinates with lymphocytes to increase granulosa cell survival and embryo quality. Am J Reprod Immunol (2005) 0.83

Drugs designed to inhibit human p38 mitogen-activated protein kinase activation treat Toxoplasma gondii and Encephalitozoon cuniculi infection. Antimicrob Agents Chemother (2007) 0.83

Paired cysteine residues are required for high levels of the Helicobacter pylori autotransporter VacA. Microbiology (2006) 0.82

The B7 homologues and their receptors in hematologic malignancies. Eur J Haematol (2012) 0.82

Modeling dynamic changes in type 1 diabetes progression: quantifying beta-cell variation after the appearance of islet-specific autoimmune responses. Math Biosci Eng (2009) 0.82

T cells and costimulation in cancer. Cancer J (2013) 0.81

Otologic assessment of blast and nonblast injury in returning Middle East-deployed service members. Laryngoscope (2013) 0.81

Endovascular repair of symptomatic renal transplant site pseudoaneurysm. Vasc Endovascular Surg (2008) 0.80

Effects of tumor irradiation on host T-regulatory cells and systemic immunity in the context of adoptive T-cell therapy in mice. J Immunother (2013) 0.80

Identification and structural determination of the M(3) muscarinic acetylcholine receptor basolateral sorting signal. J Biol Chem (2005) 0.79

Dronedarone for the treatment of atrial fibrillation: a NICE single technology appraisal. Pharmacoeconomics (2012) 0.79

Replication, immunogenicity, and protective properties of live-attenuated simian immunodeficiency viruses expressing interleukin-4 or interferon-gamma. Virology (2003) 0.79

Inhibitory B7 family members in human ovarian carcinoma. Adv Exp Med Biol (2008) 0.79

Elevated serum IL-8 is associated with the presence of hepatocellular carcinoma and independently predicts survival. Cancer Invest (2012) 0.79

T lymphocytes to IDO+ cells: check. Blood (2011) 0.78

Entheses and bones in spondyloarthritis: 2008 Annual Research and Education Meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN). J Rheumatol (2009) 0.77

CORaL: comparison of ranked lists for analysis of gene expression data. J Comput Biol (2013) 0.77

The transposed forearm loop arteriovenous fistula: a valuable option for primary hemodialysis access in diabetic patients. Ann Vasc Surg (2002) 0.77

Copper(II)/tertiary amine synergy in photoinduced living radical polymerization: accelerated synthesis of ω-functional and α,ω-heterofunctional poly(acrylates). J Am Chem Soc (2014) 0.77

Latino families' experiences with family-centered rounds at an academic children's hospital. Acad Pediatr (2011) 0.76

Nine lives for TH9s? Nat Med (2012) 0.76

Cutting down: insights from qualitative studies of smoking in pregnancy. Health Soc Care Community (2013) 0.75